Likang Life Sciences Targets Abu Dhabi for Cancer Immunotherapy Research and Expansion
Beijing-based Likang Life Sciences sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, held from October 20 to 22 at ADNEC Centre Abu Dhabi. The company shared plans to establish personalized cancer immunotherapy technologies and investigational therapies in the emirate. Co-founder and Vice Chairman Shannon Cheung met UAE leadership during the event.

